Interim analysis: the alpha spending function approach
- PMID: 7973215
- DOI: 10.1002/sim.4780131308
Interim analysis: the alpha spending function approach
Abstract
Interim analysis of accumulating data in a clinical trial is now an established practice for ethical and scientific reasons. Repeatedly testing interim data can inflate false positive error rates if not handled appropriately. Group sequential methods are a commonly used frequentist approach to control this error rate. Motivated by experience of clinical trials, the alpha spending function is one way to implement group sequential boundaries that control the type I error rate while allowing flexibility in how many interim analyses are to be conducted and at what times. In this paper, we review the alpha spending function approach, and detail its applicability to a variety of commonly used statistical procedures, including survival and longitudinal methods.
Similar articles
-
Construction of a continuous stopping boundary from an alpha spending function.Biometrics. 1998 Sep;54(3):1061-71. Biometrics. 1998. PMID: 9750252
-
Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses.J Biopharm Stat. 2014;24(4):817-33. doi: 10.1080/10543406.2014.901341. J Biopharm Stat. 2014. PMID: 24697500 Free PMC article.
-
The succession procedure for interim analysis: extensions for early acceptance of Ho and for flexible times of analysis.Stat Med. 1993 Jan 15;12(1):51-67. doi: 10.1002/sim.4780120107. Stat Med. 1993. PMID: 8446804
-
A unified theory for sequential clinical trials.Stat Med. 1999 Sep 15-30;18(17-18):2271-86. doi: 10.1002/(sici)1097-0258(19990915/30)18:17/18<2271::aid-sim254>3.0.co;2-z. Stat Med. 1999. PMID: 10474138 Review.
-
The management of interim analyses in drug development.Stat Med. 1998 Aug 15-30;17(15-16):1801-9; discussion 1811-2. doi: 10.1002/(sici)1097-0258(19980815/30)17:15/16<1801::aid-sim981>3.0.co;2-l. Stat Med. 1998. PMID: 9749448 Review.
Cited by
-
Bayesian Group Sequential Clinical Trial Design using Total Toxicity Burden and Progression-Free Survival.J R Stat Soc Ser C Appl Stat. 2016 Feb;65(2):273-297. doi: 10.1111/rssc.12117. Epub 2015 Oct 26. J R Stat Soc Ser C Appl Stat. 2016. PMID: 27034510 Free PMC article.
-
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.Trials. 2018 May 29;19(1):297. doi: 10.1186/s13063-018-2668-6. Trials. 2018. PMID: 29843781 Free PMC article.
-
Effect of a single-dose denosumab on semen quality in infertile men (the FITMI study): study protocol for a randomized controlled trial.Trials. 2022 Jun 22;23(1):525. doi: 10.1186/s13063-022-06478-4. Trials. 2022. PMID: 35733213 Free PMC article.
-
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery.N Engl J Med. 2016 Apr 7;374(14):1311-20. doi: 10.1056/NEJMoa1516783. Epub 2016 Feb 4. N Engl J Med. 2016. PMID: 26842679 Free PMC article. Clinical Trial.
-
Recent innovations in adaptive trial designs: A review of design opportunities in translational research.J Clin Transl Sci. 2023 Apr 28;7(1):e125. doi: 10.1017/cts.2023.537. eCollection 2023. J Clin Transl Sci. 2023. PMID: 37313381 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical